BioSpace News Archive

Genentech, a Roche company, and Microbiotica signed a multi-year strategic collaboration to discover, develop and commercialize biomarkers, targets and drugs for inflammatory bowel disease (IBD).

Pfizer is now throwing an additional $600 million into its venture capital fund, with a quarter of it earmarked for neuroscience research investments.

Metracrine, based in San Diego, completed a Series C financing round worth $65 million.

Canopy Growth Corporation is proud to announce that it will contribute CDN $2.5 million to the University of British Columbia (“UBC”) and BC Centre on Substance Use (“BCCSU”) to fund research into the potential utility of cannabis in addressing the overdose crisis.

Seasoned Executive Gerard Fleury Joins the Company as Chief Financial Officer

Collaboration will also generate preclinical data to inform Regeneron’s development of human medicines

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma’s website

The national law firm of Baron & Budd, and Sweeney Merrigan Law, LLP, announce that municipal leaders from throughout Western Massachusetts are taking a long-needed step forward to hold accountable the companies responsible for dumping millions of dollars’ worth of prescription opiates into their cities and towns.

7 Presentations at the 16th IMS World Congress on Menopause

Dr Philip Harris is a distinguished clinical endocrinologist and general physician, with a strong academic background. He has an extensive international network of contacts in clinical endocrine oncology and academia as well as in industry.